10 Information Technology Stocks With Whale Alerts In Today's Session
Brand Prescription Drugs to Rise an Average 4.5% in 2025
How Is The Market Feeling About Pfizer?
Citigroup Unusual Options Activity
Dogs Of The Dow: Top 10 High-Yield Stocks Offering Dividends Up To 6.8% In 2025
Sangamo Therapeutics Stock Plunges As Pfizer Terminates Hemophilia Gene Therapy Pact
US Morning News Call | Stock Index Futures Rise Ahead of the Year's Final Trading Session
January's Must-see Financial Events: CES 2025, Q4 Earnings Season, and Trump's Inauguration Day
Takeda-backed Ascentage Pharma Files for $100M IPO
Sangamo Says Collaboration, License Agreement With Pfizer On Giroctocogene Fitelparvovec Will Terminate Effective April 21, 2025; Plans To Explore All Options To Commercialize The Asset, Including Seeking Potential New Partner
Pfizer's Options: A Look at What the Big Money Is Thinking
Dow Jones 2024 Scoreboard: Top 5 Winners, Losers — And How Amazon, Nvidia Could Reshape 2025
Market Falling Monday, With Few Santa Clause 'Rally' Days Left | Live Stock
Intel's Options: A Look at What the Big Money Is Thinking
Nvidia's Supplier Ibiden Mulls Rapid Expansion Amid AI Demand - Report
US Morning News Call | Boeing Drops in Premarket as South Korea Orders Inspection of B737-800 Aircraft
Here Are Morgan Stanley's Key Oncology Catalysts for 2025
Intel Leads 2024 Tech Layoffs, but Sector Lays off 43% Less Year Over Year
Weekly Buzz: So far, Santa is Letting us Down
Catalyst Watch: Eyes on Electric Vehicle Deliveries, Retail Data and Housing Reads